Various targets were found for cancer therapy methods, such as chimeric antigen receptor T (CAR-T), cytokine-induced killer (CIKs), immune checkpoint blockade (anti-PD), and tumor-infiltrating lymphocytes (TILs). The gene discussed is TRAF3IP2; the disease is neoplasm.